At present, there are no approved antiviral drugs for Nipah and supportive care is the only option for human infections.

The virus-like particle chikungunya vaccine received accelerated approval from the FDA in February, and is one of two single-dose vaccines to prevent disease caused by the chikungunya virus.

Pepper the cat, whose owner works at the University of Florida, gathered a specimen containing a never-before-seen virus for ...

The virus-like particle chikungunya vaccine received accelerated approval from the FDA in February, and is one of two single-dose vaccines to prevent disease caused by the chikungunya virus.

Touching Base is the dynamic podcast series from the editors of GEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex ...

International researchers have built artificial virus-like particles capable of entering human cells to perform tasks such as gene editing.

A new study shows virus-like particle can effectively 'shock and kill' latent HIV reservoir in those living with chronic HIV.

--Blue Water Vaccines Inc., a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that the Company plans to explore the ...

The virus-like particle technology will be engineered and functionalized for the specific carcinoma cell type using therapeutically validated AAVs, including a novel primer compound. Hovione will be ...

Unusual genetic elements called Mavericks, which can bundle a gene inside a virus-like particle, seem to have transported a gene between many species of roundworms.